REVBW

REVELATION BIOSCIENCES, INC.

REVBW · CIK 1810560 · Annual (10-K) · Last 6 years

Financial Trends

Revenue
20202025
Net Income−$9M
20202025
Operating CF−$8M
20202025
Free Cash Flow−$8M
20202025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Revenue——————
Cost of Revenue——————
Gross Profit——————
R&D Expense$0.0B$0.0B$0.0B$0.0B——
SG&A Expense——————
Operating Income$-0.0B$-0.0B$-0.0B$-0.0B——
Net Income$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-23.95$-87.68$-0.53$-20.09$-1.17—
EPS (Diluted)$-23.95$-87.68$-0.53$-20.09——

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Total Assets$0.0B$0.0B$0.0B$0.0B$0.0B$0.1B
Current Assets$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.0B$0.0B$0.0B$-0.0B$0.0B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$-0.0B$-0.0B—$-0.0B$0.0B$-0.1B
Capital Expenditures$0.0B$0.0B—$0.0B——
Financing Cash Flow$0.0B$0.0B$0.0B$0.0B$-0.0B$0.1B
← Companies